About Blue Earth Diagnostics
Blue Earth Diagnostics is a company based in Oxford (United Kingdom) founded in 2014 was acquired by Bracco Imaging in June 2019. Blue Earth Diagnostics has raised $49.42 million across 2 funding rounds from investors including Syncona and Bracco Imaging. The company has 38 employees. Blue Earth Diagnostics has completed 1 acquisition, including Bracco Imaging. Blue Earth Diagnostics offers products and services including PET Radiopharmaceuticals, Axumin, and Posluma. Blue Earth Diagnostics operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter Oxford, United Kingdom
- Employees 38
- SectorsHealthcare
- Website blueearthdiagnostics.com
- Social LinkedIn
- Acquired by Bracco Imaging (Jun 2019)
- Legal Name Blue Earth Diagnostics Limited
- Date of Incorporation 13 Nov, 2013
- Jurisdiction OXFORD, UNITED KINGDOM
- Annual Revenue$311.88 (USD)-100as on Dec 31, 2017
- Net Profit-$1.75 K (USD)35as on Dec 31, 2017
- Total Equity Funding$49.42M (USD)
in 2 rounds
- Latest Funding Round$28.07M (USD), Series B
Jul 2015
- InvestorsSyncona
& 1 more
- Employee Count38
- Investments & Acquisitions
- Acquired byBracco Imaging
(Jun 2019)
Products & Services of Blue Earth Diagnostics
Blue Earth Diagnostics offers a comprehensive portfolio of products and services, including PET Radiopharmaceuticals, Axumin, and Posluma.
Radiopharmaceuticals for PET imaging in cancer detection
Agent for prostate cancer imaging via PET scans
Agent for prostate-specific membrane antigen imaging
Funding Insights of Blue Earth Diagnostics
Blue Earth Diagnostics has successfully raised a total of $49.42M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $28.07 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.42M
- Total Rounds 2
- Last Round Series B — $28.07M
- First Round $21.36M
(Mar 2014)
- Investors Count 1
All 2 funding rounds of Blue Earth Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Blue Earth Diagnostics
Blue Earth Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Syncona and Bracco Imaging.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments are managed via private equity by Syncona. | 2012 | synconaltd.com | London, United Kingdom | |
A portfolio of medical imaging devices for diagnostics is provided. | 2004 | braccoimaging.com | Milan, Italy |
Investor details for Blue Earth Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Blue Earth Diagnostics
Blue Earth Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bracco Imaging.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A portfolio of medical imaging devices for diagnostics is provided. | braccoimaging.com | Milan, Italy | 2004 | Jun 2019 | $450M |
Complete acquisition details for Blue Earth Diagnostics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Blue Earth Diagnostics
5 dated milestones of Blue Earth Diagnostics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Blue Earth Diagnostics is founded.
- Funding First funding round of $21.4M.
- Funding Latest funding round, Series B, of $28.1M.
- Acquisition Acquires Bracco Imaging.
- Exit Acquired by Bracco Imaging.
Competitors of Blue Earth Diagnostics
Blue Earth Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| strandls.com | 2000 | Bengaluru, India | $34.88M | 532 | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. |
Detailed competitors of Blue Earth Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Blue Earth Diagnostics
The website of Blue Earth Diagnostics (blueearthdiagnostics.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 82.7% vs previous month
Latest news on Blue Earth Diagnostics
Complete news archive for Blue Earth Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Blue Earth Diagnostics
10 companies that operate in the same segment as Blue Earth Diagnostics (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 190 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – | |
Portable MRI systems are manufactured for medical professionals. | 2014 | New York, New York, United States | – | USD 13.56 M | 111 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Blue Earth Diagnostics
Blue Earth Diagnostics was founded in 2014.
Blue Earth Diagnostics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Blue Earth Diagnostics is a funded company, having raised a total of $49.42M across 2 funding rounds to date. The company's 1st funding round was a Series A of $21.36M, raised on Mar 2014.
Blue Earth Diagnostics has 38 employees.
Annual revenue of Blue Earth Diagnostics is $311.88 as on Dec 31, 2017.
Founded in 2014 and based in Oxford, United Kingdom, radioactive molecular imaging agents for cancer detection and therapy are developed by the company. Operations center on synthetic amino acid derivatives and PSMA-targeted compounds used in PET imaging. Fluciclovine (18F) is employed for prostate cancer and brain metastases visualization, while rhPSMA-7.c supports PET scanning for prostate cancer, and rhPSMA facilitates radiopharmaceutical therapy in the same area.
Blue Earth Diagnostics's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
Blue Earth Diagnostics offers PET Radiopharmaceuticals, Axumin, and Posluma.
Blue Earth Diagnostics has made 1 acquisition, including Bracco Imaging.
Blue Earth Diagnostics has 2 investors. Key investors include Syncona, and Bracco Imaging.
Blue Earth Diagnostics operates through Blue Earth Diagnostics Limited.
Yes. Blue Earth Diagnostics was acquired by Bracco Imaging in June 2019.